Invion Ltd - Asset Resilience Ratio

Latest as of June 2025: 8.96%

Invion Ltd (IVX) has an Asset Resilience Ratio of 8.96% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$850.37K

≈ $601.69K USD Cash + Short-term Investments

Total Assets

AU$9.49 Million

≈ $6.71 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2022)

This chart shows how Invion Ltd's Asset Resilience Ratio has changed over time. Check IVX strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Invion Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Invion Ltd (IVX) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$850.37K	8.96%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$850.37K	8.96%

Asset Resilience Insights

Limited Liquidity: Invion Ltd maintains only 8.96% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Invion Ltd Industry Peers by Asset Resilience Ratio

Compare Invion Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Alkem Laboratories Limited NSE:ALKEM	Drug Manufacturers - Specialty & Generic	31.91%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	28.06%
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	Drug Manufacturers - Specialty & Generic	4.97%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Invion Ltd (2002–2022)

The table below shows the annual Asset Resilience Ratio data for Invion Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-06-30	42.28%	AU$8.47 Million ≈ $6.00 Million	AU$20.04 Million ≈ $14.18 Million	+23.90pp
2021-06-30	18.38%	AU$1.04 Million ≈ $733.62K	AU$5.64 Million ≈ $3.99 Million	+2.59pp
2017-06-30	15.79%	AU$917.49K ≈ $649.18K	AU$5.81 Million ≈ $4.11 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$11.98 Million ≈ $8.48 Million	--
2007-06-30	42.43%	AU$1.58 Million ≈ $1.12 Million	AU$3.74 Million ≈ $2.64 Million	-29.52pp
2002-06-30	71.95%	AU$1.07 Million ≈ $754.97K	AU$1.48 Million ≈ $1.05 Million	--

pp = percentage points

About Invion Ltd

AU:IVX Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.36 Million

AU$3.34 Million AUD

Market Cap Rank

#29790 Global

#1727 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.15

All Time High

AU$4.80